Gazyva/Gazyvaro (obinutuzumab) was found to significantly improve complete renal response in lupus nephritis patients, ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

VitusCare has developed proprietary playbooks to find the right hospital partners, fast-track centre-launches and use ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...

AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business impact of the Chinese investigations remains minor.

Like most people who have been diagnosed with a life-threatening disease, Ruel Bautista is still trying to come to terms with ...

Genentech, a member of Roche (RHHBY), announced that a detailed analysis of its Phase III REGENCY trial of Gazyva in people with active lupus ...

VANCOUVER — Transit workers in British Columbia's Cowichan Valley have launched strike action, shutting down services in the ...

This study highlights the first successful cases of robot-assisted kidney transplantation following cystectomy, paving the ...

Genesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the successful transplantation of a genetically engineered porcine ...

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of ...

Background The Prognostic Nutritional Index (PNI), calculated from serum albumin levels and lymphocyte counts, is a simple ...